BioSpace News Archive

MindBio Therapeutics Corp. is pleased to have started pre-screening for participant entry into Phase 2 LSD-Microdosing clinical trials.

Telix Pharmaceuticals Limited issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 June 2023.

Elgan Pharma announced that it has been awarded by the European Innovation Council a grant of €2.36 million in a highly competitive selection process.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced that it has submitted a Clinical Trial Application to initiate a Phase 1/2 clinical trial of OTOF-GT in Europe.

Catalyst Pharmaceuticals, Inc., announced the completion of its acquisition from Santhera Pharmaceuticals Holdings of an exclusive license for North America for vamorolone, a potential treatment for patients suffering with Duchenne Muscular Dystrophy.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that University Hospitals Seidman Cancer Center has joined the Caris Precision Oncology Alliance™.

MeMed, a leader in the emerging field of advanced host response technologies, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for use of the MeMed BV® test on whole blood samples on the point-of-need MeMed Key® analyzer to help healthcare providers distinguish between bacterial and viral infections in 15 minutes.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. Food and Drug Administration approval for its ninth ADMA BioCenters plasma collection facility located in Dallas, GA.

CytoSorbents Corporation announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023.

XRHealth, the leading healthcare platform in the Spatial computing, announces today that they published a new study in BMC, proving the effectiveness of treating lower back and neck pain in the metaverse.